# Vorinostat in Children

> **NCT01422499** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Center for Tumor Diseases, Heidelberg** · enrollment: 50 (actual)

## Conditions studied

- Children With Relapsed Solid Tumor, Lymphoma or Leukemia

## Interventions

- **DRUG:** zolinza/vorinostat

## Key facts

- **NCT ID:** NCT01422499
- **Lead sponsor:** National Center for Tumor Diseases, Heidelberg
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2017-03-24
- **Final completion:** 2017-03-24
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-04-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01422499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01422499, "Vorinostat in Children". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01422499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*